Related Experiment Video
Updated: Mar 25, 2026

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
Published on: May 5, 2016
Companies Take Aim at MRSA Infections
Abstract:
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most widespread and virulent nosocomial pathogens. The late-stage clinical pipeline includes an array of proposed new treatments aimed at MRSA-related skin infections and pneumonia.
Insights
Methicillin-resistant Staphylococcus aureus (MRSA) is a major hospital pathogen. New treatments are in development for MRSA-related skin infections and pneumonia.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant nosocomial pathogen.
- MRSA infections pose a substantial threat in healthcare settings.
- The virulence of MRSA necessitates the development of novel therapeutic strategies.
Purpose of the Study:
- To review the current landscape of late-stage clinical treatments for MRSA.
- To identify promising therapeutic candidates for MRSA-related infections.
- To address the unmet medical needs in treating MRSA skin infections and pneumonia.
Main Methods:
- Literature review of clinical trials and research pipelines.
- Analysis of proposed treatment mechanisms and targets.
- Evaluation of therapeutic efficacy and safety profiles.
Main Results:
- Several novel treatment candidates are progressing through late-stage clinical development.
- These treatments target various aspects of MRSA pathogenesis.
- The pipeline includes options for both skin infections and pneumonia.
Conclusions:
- The clinical pipeline shows promise for addressing MRSA infections.
- Advancements in treatment strategies are crucial for combating this virulent pathogen.
- Continued research and development are essential for effective MRSA management.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Bacterial Signaling

